Find verified Mycophenolate mofetil hydrochloride API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Mycophenolate mofetil hydrochloride for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Mycophenolate mofetil hydrochloride API.
Alternate Names: Cellcept (TN), Mycophenolate mofetil (hydrochloride)
CAS No: 116680-01-4
PubChem CID: 6441022
Mol Formula: C23H32ClNO7
Mol Weight: 470.0 g/mol
IUPAC Name: 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;hydrochloride
API Description: MYCOPHENOLATE MOFETIL HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1998. This drug has a black box warning from the FDA. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.
